Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06699927 · ClinicalTrials.gov registry record · Early Phase 1

Working Memory Training for People Aging with HIV

A Early Phase 1 study of Cognitive Change, sponsored by Northeastern University.

Recruiting
Registry status
Early Phase 1
Development phase
80
Enrollment target
1
Study location

NCT06699927 is a Early Phase 1 study of Cognitive Change that is actively recruiting participants, run by Northeastern University. The registered enrollment target is 80 participants, below the 178-participant average among 44 other Cognitive Change trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06699927, a Early Phase 1 study of Cognitive Change, is actively recruiting participants, sponsored by Northeastern University.

RECRUITING
Registry status
Early Phase 1
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The present study investigates the feasibility of working memory training in people aging with HIV (PAWHIV). In a cross-over design this stage 1 feasibility trial, will evaluate acceptability, and estimate possible effect sizes related to working memory training by examining potential differential effects in PAWHIV and those aging without HIV. This project highlights the importance of tailored cognitive assessments and interventions, engaging with underrepresented communities to enhance inclusivity in cognitive health research.

Conditions Studied

Interventions

  • BEHAVIORAL Span

Study Locations (1)

Massachusetts

  • Northeastern University - Boston

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2024-07-15
Est. Completion 2025-12-31
Phase Early Phase 1

Sponsor

Northeastern University

39 total trials

What the Registry Record Tells You About NCT06699927

The ClinicalTrials.gov registry entry for NCT06699927 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 178-participant average among 44 other Cognitive Change trials with a reported enrollment target (55% lower). The listed sponsor is Northeastern University, which has 39 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cognitive Change appearing as the primary indexed condition, and to 1 intervention - of which Span is the first listed.

NCT06699927 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06699927 about?

NCT06699927 is a clinical study titled "Working Memory Training for People Aging with HIV". The present study investigates the feasibility of working memory training in people aging with HIV (PAWHIV). In a cross-over design this stage 1 feasibility trial, will evaluate acceptability, and estimate possible effect sizes related to working memory training by examining potential differential e...

What is the current status of trial NCT06699927?

This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 80 participants. The study started on 2024-07-15. Estimated completion is 2025-12-31.

What conditions does trial NCT06699927 study?

This clinical trial studies the following conditions: Cognitive Change.

What interventions are being tested in trial NCT06699927?

The interventions under investigation include: Span (BEHAVIORAL).

Who is sponsoring clinical trial NCT06699927?

This trial is sponsored by Northeastern University, which has 39 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06699927 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cognitive Change

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.